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Abstract The nuclear matrix has been linked to several important cellular functions within cells, such as DNA 
organization and replication, as well as regulation of gene expression. It has been reported that the nuclear matrix 
protein composition is altered in cells grown on different extracellular matrices in vitro. This study examined the nuclear 
matrix protein composition of tumors produced by MAT-LyLu (MLL) rat prostate tumor cells implanted at different organ 
sites within the rat. When high resolution two-dimensional gels were utilized to compare nuclear matrix protein 
composition to the prostate orthotopic tumor, it was found that there were distinct protein differences depending upon 
where the tumor grew. In particular, there were 14 proteins found in the lung, six proteins found in intramuscular, 1 7  
proteins is the heart, and five proteins in the tail vein tumor tissue that were not present in the prostate orthotopic tumor 
tissue. Therefore, this study adds evidence to support that the nuclear matrix composition of a cell is dependent, at least 
in part, by the extracellular matrix and/or different cellular environments and may have a role in site-specific differences 
in tumor properties. 
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The structures and functions of a cell are 
dependent on a cell matrix system which ex- 
tends from the cell periphery to the DNA [Get- 
zenberg et al., 19901. Experimental evidence of a 
cellular matrix system came when electron mi- 
crographs clearly demonstrated the linkages of 
the cellular periphery, cytoskeleton, and the 
nuclear matrix [Fey et al., 19841. The physical 
connections between the nucleus and cytoskel- 
eton have been reported to be functionally al- 
tered in transformed cells [Pienta and Coffey, 
19921. The tissue matrix system includes the 
linkages of the cell matrix to the extracellular 
matrix (ECM) [Getzenberg et al., 19901. Extra- 
cellular signals within the ECM, when exposed 
to the appropriate receptorb) on a cell mem- 
brane, can transverse into the cytoplasm andlor 
nucleus by utilizing these matrix networks. 
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Therefore, what a cell touches (i.e., ECM) helps 
determine what the cell will do. The ECM ap- 
pears to control nuclear shape in rat hepatocytes 
and multiple studies have demonstrated that 
alterations in cell shape, determined at least in 
part by the matrix networks, can also induce 
DNA, RNA, and protein synthesis [Mooney et 
al., 19951. DNA synthesis is regulated by cell 
shape and DNA metabolism appears to be linked 
with physical expansion of the cell and nucleus 
[Ingber et al., 1987; Folkman and Moscona, 
19781. Primary rat hepatocytes, when grown on 
different extracellular matrices, have been dem- 
onstrated to exhibit altered gene expression 
[Hansen et al., 19941. mRNA expression has 
also been reported to be altered when cells were 
grown on different extracellular matrices. In 
particular, the amount of insulin mRNA present 
in cultured hepatocytes has been shown to be 
dependent upon the ECM used [Muschel et al., 
19861. 
The nuclear matrix is an important part of the 
cell’s networking system. The nuclear matrix is 
the RNA-protein skeleton of the nucleus which 
contributes to the structural and functional or- 
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ganization of DNA. The nuclear matrix consists 
of peripheral lamins, pore complexes, residual 
nucleoli, and a RNA-protein network [Berezney 
and Coffey, 1974; Berezney and Buchholtz, 1981; 
Barrack and Coffey, 1982; Nelson et al., 1986; 
Berezney, 1991; Pienta et al., 1991aI. The 
nuclear matrix has been demonstrated to play 
roles in several functions, including DNA organi- 
zation and replication, RNA synthesis and trans- 
port, and the regulation of gene expression. The 
nuclear matrix provides the framework on which 
loop domains of DNA are organized. The sites at 
which DNA is attached to the matrix are called 
matrix associated regions or scaffold attach- 
ment regions and these attachment sites have 
been identified as the location of actively tran- 
scribed genes and viruses [Robinson et al., 1983; 
Ciejek et al., 19831, including chicken lysozyme 
locus [McKnight et al., 19921, SV40 [Abulafia et 
al., 19841, and vitellogenine I1 [Jost and Sel- 
dran, 19841. A number of components impor- 
tant in gene regulation including steroid recep- 
tors and transcription factors have been 
demonstrated to be associated with the nuclear 
matrix [Barrack and Coffey, 1980; Merriman et 
al., 1995; Nardozza et al., in press]. The nuclear 
matrix proteins have been shown to vary in a 
cell type-specific manner indicating that the 
nuclear matrix may play an important role in 
the tissue-specific three-dimensional organiza- 
tion of DNA [Getzenberg and Coffey, 1990; Fey 
et al., 1984; Getzenberg et al., 1991al. Since the 
nuclear matrix appears to play major roles in the 
normal functions of a cell, it has been proposed 
that the alterations of these nuclear matrix pro- 
teins may play a role in altered gene function. 
Evidence of this is found in cancer cells, where 
altered cell function is paralleled by changes in 
nuclear matrix composition [Berezney et al., 
1979; Getzenberg et al., 1991; Khanuja et al., 
1993; Partin et al., 1993; Keesee et al., 1994; 
Donat et al., 1996; Getzenberget al., in press]. 
Cells grown on different extracellular matri- 
ces have been reported to have altered morpho- 
logic and phenotypic characteristics. Normal rat 
kidney (NRK) cells plated onto matrigel (a tu- 
mor secreted basement membrane) exhibited 
changes in cell area, morphology, nuclear/ 
cytoplasmic ratios, cell motility, as well as a loss 
of contact inhibition [Pienta et al., 1991bl. The 
nuclear matrix composition of these cells were 
found to be altered as well [Getzenberg et al., 
1991bI. Comparisons of fetal rat calvaria osteo- 
blast cells grown on either collagen type I or 
plastic matrices were also found to exhibit alter- 
ations in gene expression, mRNA levels, and 
matrix mineralization [Lynch et al., 19951. The 
purpose of this study, therefore, was to examine 
the differences of nuclear matrix protein compo- 
sition in vivo by comparing nuclear matrix pro- 
tein compositions of tumors grown at different 
organ sites in the rat by injections of the MLL 
prostate cancer cell line. 
METHODS 
Cell Lines 
MAT-LyLu (MLL, Metastatic, Anaplastic, Tu- 
mor to Lymph nodesand Lungs) cell line Gas 
maintained in RPMI 1640supplemented with 
10% fetal bovine serum and 1% penicillin/ 
streptomycin solution. Cell culture reagents were 
obtained from Sigma (St. Louis, MO). 
Tumor Samples 
Cells growing in culture were detached using 
trypsin followed by neutralization with media. 
Cells were pelleted and resuspended in Hanks 
Buffered Salt Solution (HBSS). One million cells 
( 100 ~ 1 )  were injected intramuscularly, directly 
into the tail vein, heart, lung, or prostate of male 
Copenhagen rats (200-250 g) (Harlan, India- 
napolis, IN). One injection was given per rat. 
Two to four rats were injected per organ site. 
Tumors were allowed to grow from 2-4 weeks to 
ensure ample tumor size. The largest tumor 
produced at each site was used for nuclear ma- 
trix isolation (i.e., tumors were not mixed). Tu- 
mors were removed and placed into l x  phos- 
phate buffered saline containing 1 mM 
phenylmethlsulfonyl fluoride (PMSF) on ice to 
inhibit protease activity. Tissue was dounced on 
ice for 15 min followed by centrifugation at  780 
rpm for 10 min. Supernatant was removed and 
the cells underwent nuclear matrix isolation. 
Analysis of Nuclear Matrix Proteins 
Nuclear matrix preparation. Nuclear ma- 
trices were prepared using the methodologies 
described elsewhere [Fey and Penman, 1988; 
Getzenberg et al., 19901. Pellets were suspended 
in 0.5% Triton X-100 and 2 mM vanadyl ribo- 
nucleoside and placed on ice for 20 min to  re- 
lease the lipids and soluble protein. Soluble cyto- 
skeletal elements were released following a 0.25 
M ammonium salt extraction with vanadyl ribo- 
nucleoside for 10 min on ice. The pellet was 
resuspended in chromatin buffer (50 mM NaC1, 
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Fig. 1 .  
cells. This gel was used to compare the remaining nuclear matrix tumor protein compositions. 
High-resolution two-dimensional gel electrophoresis of a prostate tumor derived from an injection of MLL 
300 mM sucrose, 10 mM Pipes (pH 6.81, 5 mM 
MgC12, 0.5% Triton X-100, 1.2 mM phenylmeth- 
ylsulfonyl fluoride (PMSF), and 100 pg/ml 
DNase 1) and incubated for 20 min at 20°C. 
Samples were centrifuged and resuspended in 
cytoskeleton buffer (100 mM NaC1, 300 mM 
sucrose, 10 mM Pipes (pH 6.8), 5 mM MgC12, 
0.5% TritonX-100,1.2 mM PMSF, and 25 p,g/ml 
RNase A) for 10 min at 20°C. The remaining 
fraction was disassembled by overnight dialysis 
with a buffer containing 8 M urea, 20 mM 
2-(N-morpholino)ethanesulfonic acid (pH 6.61, 
1 mM ethyleneglycol bit@-aminoethyl ether)- 
N,N,N’,N’-tetraacetic acid, 1 mM PMSF, 0.1 
mM MgC12, and 1% 2-mercaptoethanol. The re- 
maining intermediate filaments were reas- 
sembled using a buffer containing 0.15 M KC1, 
25 mM imidazole hydrochloride, 5 mM MgC12, 
2 mM dithiothreitol, 0.125 mM ethyleneglycol 
bis (P-aminoethyl ether)-N,N,N’,N’-tetraacetic 
acid, and 0.2 mM PMSF and separated out by 
centrifugation. The soluble nuclear matrix pro- 
teins were ethanol precipitated at -20°C. All 
solutions contained freshly made 1 mM PMSF 
to inhibit serine proteases. The protein was re- 
suspended in 20 p,l of sample buffer (9 M urea, 
65 mM CHAPS,  140 mM dithiothreitol, and 
2.2% ampholytes). Coomassie Plus assay (Pierce, 
Rockford, IL) was used for protein determina- 
tion using bovine serum albumin as a standard. 
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Fig. 2. High-resolution two-dimensional gel electrophoresis of a lung tumor derived from an injection of MLL cells. 
L-1 through L-14 represent nuclear matrix proteins that were not found in the prostate tumor nuclear matrix 
composition. 
Two-Dimensional Electrophoresis 
High resolution two-dimensional electropho- 
resis was carried out using the Investigator 2-D 
Electrophoresis System from Oxford Glycosys- 
tems (Bedford, MA). Tube gels were cast fol- 
lowed by prefocusing until the maximum volt- 
age reached 1500 volts. 40 p,g of sample was 
loaded onto glass tubes with a 1 mm inner 
diameter and isoelectric focusing was carried 
out using pH 3-10 ampholytes optimized for 
separation of cellular proteins (Oxford Glycosys- 
terns) for 18,000 volt h. Tube gels were extruded 
and incubated in gel equilibration buffer (0.3 M 
Tris base, 0.075 M Tris-HC1, 3.0% sodium do- 
decyl sulfate, 50 mM dithiothreitol, and 0.01% 
bromophenol blue) for two min at room tempera- 
ture. Each tube gel was placed on top of a 10% 
polyacrylamide gel and run for approximately 
5 h at  20,000 mW per gel. Gels were fixed over- 
night in 50% methanol/lO% acetic acid, en- 
hanced with 5% gluteraldeyde followed by silver 
staining using an Accurate Chemical silver stain- 
ing kit (Accurate Chemical Co., Inc., Westbury, 
NY) as described elsewhere Wray et al., 19811. 
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Fig. 3. High-resolution two-dimensional gel electrophoresis of an intramuscular tumor derived from an injection of 
MLL cells. IM-1 through IM-6 represent nuclear matrix proteins that were not found in the prostate tumor nuclear 
matrix composition. 
Protein molecular weight standards were ob- 
tained from Diversified Biotechnology (Boston, 
MA). Isoelectric points were determined using 
BDH carbamylated standards (Gallard-Schle- 
singer, Carle Place, NY) and Sigma Chemical 
Co. (St. Louis, MO). When sufficient tumor ma- 
terial was available, multiple gels were run for 
each sample. Only protein spots clearly and re- 
producibly observed in all the gels of a sample 
type were counted as actually representing the 
nuclear matrix components. The gels were ana- 
lyzed using the BioImage 2D Electrophoresis 
Analysis System (BioImage, Ann Arbor, MI) 
which matches protein spots between gels and 
databases the gels and protein spots. Organ sites 
were compared to the gel produced by MLL cells 
injected into the orthotopic site of the prostate. 
RESULTS 
This study investigated the nuclear matrix 
protein composition from MLL prostate cancer 
cells growing at  various organ sites in the rat. 
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Fig. 4. High-resolution two-dimensional gel electrophoresis of a heart tumor derived from an injection of MLLcells. 
H-I through H-17 represent nuclear matrix proteins that were not found in the prostate tumor nuclear matrix 
composition. 
MLL prostate cancer cells were injected into the 
prostate, lung, heart, intramuscular, and tail 
vein producing tumors which were used for the 
isolation of nuclear matrix. Nuclear matrix 
samples were analyzed by their protein pattern 
revealed by two-dimensional electrophoresis. The 
heart, lung, intramuscular, and tail vein nuclear 
matrix protein compositions were compared only 
to the prostate tumor nuclear matrix pattern. 
This comparison was chosen since the MLL cell 
line was originally derived from a rat prostate 
tumor. Upon comparison, there were distinct 
protein differences, as well as common proteins, 
seen in all of the organ nuclear matrix protein 
compositions when compared to the prostate 
derived nuclear matrix. Figure 1 shows the two- 
dimensional nuclear matrix pattern of the pros- 
tate derived tumor by which all other gels were 
compared. Approximately 150 proteins spots 
were identified ranging in size from 10-200 kD 
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Fig. 5. High-resolution two-dimensional gel electrophoresis of a tail vein tumor derived from an injection of MLL 
cells. n/-1 through Tv-5 represent nuclear matrix proteins that were not found in the prostate tumor nuclear matrix 
composition. 
and PI from 5.0-9.3. When compared to the 
prostate protein pattern, fourteen proteins were 
identified as being present only in the lung (L-1 
through L-14) (Fig. 2). The proteins ranged 
from approximately 18 kD-95 kD while the PI 
ranged from 6.2-7.0. Seven proteins (L5-L-11) 
were present in a cluster of 30-36 kD and PI 
6.6-6.9. Six proteins were found that were only 
present in the intramuscular tumor tissue (IM-1 
through IM-6) (Fig. 3). These proteins ranged 
from approximately 14 kD-40 kD with PIS from 
6.9-9.4. Seventeen proteins (H-1 through H-17) 
were found only in the heart tumor tissue when 
compared to the prostate nuclear matrix pattern 
(Fig. 4) and ranged from 14-89 kD and PIS from 
6.0-8.8. H2-H8 were identified as a distinct 
group of proteins of 55-70 kD and PI 6.1-6.3. 
Five proteins (TV-1 through TV-5) were present 
in tail vein tumor tissue and not in the prostate 
tumor tissue (Fig. 5). These proteins ranged 
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Fig. 6. A schematic representation of the high-resolution two-dimensional electrophoresis of the nuclear matrix 
proteins from MLL-producing tumors in the lung 0 (L-1 through L-l4), intramuscular H (IM-1 through IM-6), tail 
vein 0 (W-1 through W - 5 ) ,  and heart 0 (H-1 through H-17) when compared to the prostate tumor. Only protein 
differences are shown. 
from approximately 19-36 kD and PIS from 
6.0-6.4. Figure 6 is a schematic representation 
of all of the different nuclear matrix proteins 
seen in all of the tumor tissues studied upon 
comparison to the prostate derived tumor. 
DISCUSSION 
The nuclear matrix has been implicated in 
critical functions of the cell, including replica- 
tion, DNA organization, and transcription. Upon 
comparison of nuclear matrices from normal 
cells and their cancerous counterparts, it was 
found that distinct differences do exist [Be- 
rezney et al., 1979; Getzenberg et al., 1991; 
Khanuja et al., 1993; Partin et al., 1993; Keesee 
et al., 1994; Donat et al., 1996; Getzenberg et al., 
in press]. This study was undertaken to com- 
pare the nuclear matrix protein compositions in 
vivo of MLL prostate tumors growing at other 
organ sites in the rat. Upon comparison of the 
various organ sites to the nuclear matrix protein 
pattern produced by the prostate tumor, it was 
found that there were proteins present in the 
various tumor types that were not present in the 
tumor of the prostate. At least 17 proteins were 
present in the heart, six proteins in the muscle, 
14 proteins in the lung, and five proteins in the 
tail vein that were not found in the prostate 
tumor. These proteins appeared to be organ 
specific and are listed in Table I. 
Different expression of nuclear matrix pro- 
teins produced by the same cell line when grown 
at  various organ sites may be due to  the differ- 
ent environmental conditions at  the various or- 
gans. Organs of the body are subjected to  differ- 
ent macro- and microenvironments which may 
cause alterations in the transcriptional activity 
of genes as well as DNA replication resulting in 
different expression of nuclear matrix proteins. 
Different environments can be caused by the 
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Table I. Proteins Present in Heart (H-1 
Through H-17), Intramuscular (IM-1 Through 
IM-6), Lung (L-1 Through L-14), and Tail 
Vein (TV-1 Through TV-5) Not Found 
in the Prostate 































































































































presence of different hormones andl or varying 
levels of hormones, variations in blood supply, 
or other chemical or electrical signals that are in 
direct contact with the cell. 
A second possibility for the altered nuclear 
matrix protein compositions may be due to  the 
differing extracellular matrices and normal or- 
gan cells that are in direct contact with the 
tumor cells. There is a great deal of evidence to 
suggest that what a cell touches (i.e., the extra- 
cellular matrix) plays a major role in determin- 
ing how a cell functions. Investigations into the 
effects of differing extracellular matrices on vari- 
ous cells have been reported. In particular, nor- 
mal rat kidney cells (NRK) and Kirsten-rats 
transformed normal rat kidney cells (KNRK), 
when plated onto matrigel (a basement mem- 
brane secreted by sarcoma cells) were found to 
adopt a morphologic and phenotypic characteris- 
tics that closely resemble KNRK cells [Pienta et 
al., 1991bI. This suggests that matrigel may 
cause morphologic transformations through un- 
known mechanisms. These observations were 
further studied by the same laboratory using 
high resolution two-dimensional electrophore- 
sis analysis [Getzenberg et al., 19911. It was 
found that there were distinct protein differ- 
ences present in NRK and KNRK cells grown on 
different extracellular matrices. Such changes 
in the nuclear matrix protein composition have 
been suggested to be influenced by transcription 
factor binding to “extracellular matrix-response 
elements” present in promoters in some genes, 
such as p-casein [Boudreau et al., 19951. Al- 
though there were differences in the nuclear 
matrix protein composition between the differ- 
ent organ sites within the rat, differences in the 
prostate-specific gene expression were not exam- 
ined. Analysis of these nuclear matrix protein 
differences will begin to differentiate between 
these potential explanations. 
The nuclear matrix patterns from each tumor 
type were produced within a single rat (i.e., 
multiple tumors at the same organ site pro- 
duced in different rats were not individually 
analyzed). Although their may be differences if 
one were to examine the same tumor type pro- 
duced by different rats, we feel that these differ- 
ences would be minor due to the fact that the 
rats utilized in this study were from the same 
genetic background and exposed to the same 
conditions. In summary, nuclear matrix protein 
differences were seen in tumors produced by 
MLL prostate cancer cells in various organ sites 
when compared to the tumor produced by at  the 
prostate. Such differences add evidence to the 
environmental influence on nuclear compo- 
nents in the cell which may in turn cause differ- 
ential expression of genes. 
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